NuCana plc
NCNA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001709626
No open-market purchases or sales by NuCana plc insiders were filed in the last 90 days; 10 institutions reported holding it in 13F filings for Q2 2026, worth $167.9K in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in NuCana plc as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 18
- +3 vs. Q2 2024
- Shares held
- 259.0K
- −83.1K (−24.3%) vs. Q2 2024
- Total value
- $589.9K
- −$276.6K (−31.9%) vs. Q2 2024
- New holders
- 6
- 2 more added
- Sold out
- 3
- 1 more reduced
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NCNA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 10 | $167.9K |
| Q1 2026 | 8 | $79.5K |
| Q4 2025 | 9 | $643.4K |
| Q3 2025 | 10 | $835.6K |
| Q2 2025 | 17 | $38.8K |
| Q1 2025 | 12 | $238.2K |
| Q4 2024 | 20 | $532.0K |
| Q3 2024 | 18 | $589.9K |
| Q2 2024 | 15 | $866.6K |
| Q1 2024 | 23 | $2.05M |
| Q4 2023 | 24 | $3.89M |
| Q3 2023 | 21 | $8.34M |
| Q2 2023 | 21 | $10.8M |
| Q1 2023 | 25 | $13.2M |
| Q4 2022 | 27 | $9.18M |
| Q3 2022 | 28 | $14.7M |
| Q2 2022 | 26 | $10.0M |
| Q1 2022 | 34 | $15.0M |
| Q4 2021 | 38 | $44.7M |
| Q3 2021 | 31 | $47.5M |
| Q2 2021 | 33 | $58.7M |
| Q1 2021 | 35 | $129.0M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding NuCana plc; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Carlyle Group Inc. | 133,333 | $304.0K | 0.03% | 00.0% | Unchanged |
| Baillie Gifford & Co | 36,704 | $84.4K | 0.00% | −109,656−74.9% | Reduced |
| Acadian Asset Management LLC | 23,624 | $52.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 16,818 | $38.7K | 0.00% | 00.0% | Unchanged |
| Glass Jacobson Investment Advisors llc | 15,000 | $34.5K | 0.01% | 00.0% | Unchanged |
| UBS Group AG | 12,604 | $29.0K | 0.00% | +12,598+209,966.7% | Added |
| HRT Financial LP | 10,745 | $24.0K | 0.00% | +10,745 | New |
| Morgan Stanley | 5,044 | $11.6K | 0.00% | +3,480+222.5% | Added |
| Tower Research Capital LLC (TRC) | 1,842 | $4.24K | 0.00% | +1,842 | New |
| Rhumbline Advisers | 1,127 | $2.59K | 0.00% | +1,127 | New |
| Edmond de Rothschild Holding S.A. | 1,000 | $2.29K | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 613 | $1.41K | 0.00% | +613 | New |
| Federation des caisses Desjardins du Quebec | 211 | $485 | 0.00% | 00.0% | Unchanged |
| AllSquare Wealth Management LLC | 205 | $472 | 0.00% | 00.0% | Unchanged |
| Newbridge Financial Services Group, Inc. | 68 | $156 | 0.00% | +68 | New |
| Activest Wealth Management | 33 | $76 | 0.00% | 00.0% | Unchanged |
| Global Retirement Partners, LLC | 4 | $9 | 0.00% | 00.0% | Unchanged |
| Danske Bank A/S | 2 | $5 | 0.00% | +2 | New |
| Ronald Blue Trust, Inc. | 0 | $0 | 0.00% | −2,220−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −1,675−100.0% | Sold out |
| Castleview Partners, LLC | 0 | $0 | 0.00% | −5−100.0% | Sold out |